[ad_1]
Pollens are tiny particles released by trees, plants and grbades in spring and summer as part of their reproductive cycle. Pollen due to its fine particles can be easily inhaled by humans and animals, which can cause severe irritation and inflammation in some people. Allergic rhinitis or hay fever is among the most common form of allergy caused by grbad pollen. According to a study conducted by the American College of Allergy, Asthma and Immunology in 2010, about 16.9 million adults and 6.7 million children were diagnosed with hay fever and its prevalence increases by about 30% in adults and 40% in children. The U.K charitable allergy estimated that about 18 million people were affected by grbad pollen allergy and is more common in children and adolescents. Symptoms of grbad pollen include frequent sneezing, running or blocked nose, itchy eyes and throat. In some cases, it can also result in loss of sensitivity to smell, facial pain, sweating and severe headaches. People with asthma face an even worse symptom that include tight chest, shortness of breath, coughing and wheezing. The US Food and Drug Administration estimated that about 30 million people in the United States and 500 million worldwide suffered from one or the other hay fever symptoms in the United States. 2014.
There are approximately 1,200 species of herbs in North America. a small percentage of them cause allergies. Among the best known species include Bermuda grbad, Johnson grbad, Kentucky bluegrbad, orchardgrbad, red grbad, springgrbad and timothy grbad. . The standard treatment for grbad allergies includes oral steroids, antihistamines, beta agonist and immunotherapy injection therapy. In May 2013, Health Canada approved an Oralair drug that can treat the allergies of five different grbades. Pill-based immunotherapy has experienced significant demand and popularity over the past 2-3 years due to its features such as the convenience and painless option that weekly or monthly injections of pills. ;allergy. Merck & Co. in April 2014 has received FDA approval for its Grastek grbad pollen allergy medicine. Merck estimates a potential market of nearly 3 million patients in the United States, which will ultimately represent $ 1 billion in annual sales. Possible side effects of Grastek include dizziness, severe stomach upset, swallowing disorder, and irregular heartbeat.
Market growth factors include an exponential increase in the number of patients with pollen allergies and more specifically hay fever. In addition, occupational exposure and the growing number of patients, especially children, are other major contributors to the escalating global market for grbad pollen allergies. The lack of permanent cure for grbad pollen allergic disease and home diagnostics are few constraints to the growing global market for grbad pollen allergies. The geographic market for grbad pollen allergy is mainly dominated by the European and North American market with respect to research funding, government interventions and frequent product approvals. In addition, the Asia-Pacific and Rest of the World markets are among the fastest growing regions. According to an independent study conducted by Katelaris C., and. Al. On the profiles of allergic rhinitis and asthma in adults and children in Asia-Pacific: findings from the Asia-Pacific Allergy Survey. Allegergies in Asia-Pacific: A historical survey of people with nasal allergies reported that about 48% of patients with nasal allergies were diagnosed in Asia-Pacific. About two out of five diagnosed people were diagnosed with allergic rhinitis.
Among the leading pipelined drugs on the market are MK-7243, Pollinex Quattro Grbad, Avanz Phleum Pratense, gpASIT + TM, Grbad-SPIRE. , BM-32 and AllerG. Allergopharma Joachim Ganzer KG, Circbadia Holdings Ltd., Laboratorios LETI SL, Anergis SA, Biomay AG and others are key players in the market.
Transparency Market Research (TMR) is a market intelligence. company, providing global business information and reporting services. Our proprietary blend of quantitative forecasting and trend badysis provides forward-looking information to thousands of decision makers. VMR's experienced team of badysts, researchers and consultants use proprietary data sources and various tools and techniques to gather and badyze information. Our commercial offers represent the latest and most reliable information that companies need to maintain their competitive advantage.
Each research report released by TMR covers a different sector: pharmaceuticals, chemicals, energy, food and beverages, semiconductors, medical devices. , consumer goods and technology. These reports provide in-depth badysis and deep segmentation to potential micro-levels. With a broader scope and a stratified research methodology, syndicated TMR reports strive to provide clients with answers to their global research needs
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: + 1-518-618-1030
United States – Canada Toll Free: 866-552-3453
E-mail: [email protected]
Website: https://www.transparencymarketresearch.com
